Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (231,226)	$ (2,677,655)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Depreciation	33,769	33,842
Amortization of intangible assets	24,537	50,748
Written-off prepayments		122,514
Impairment loss on marketable securities		2,001,013
Gain on disposal of marketable securities	(176,870)
Loss on disposal of a subsidiary		70,901
Amortization of debt discount	2,821
Changes in operating assets and liabilities:
Accounts receivable	12,982	(9,567)
Prepaid and other receivables	15,593	28,450
Accounts payable and accrued expenses	(40,846)	3,063
Other payables	23,431	17,506
Income tax payable		(6,802)
Deferred revenue	(107)	589
CASH FLOWS USED IN OPERATING ACTIVITIES	(335,916)	(365,392)
CASH FLOWS FROM INVESTING ACTIVITIES:
Dividend received	1,722
Purchase of marketable securities	(15,750,381)
Proceed from disposal of marketable securities	14,739,214
Proceed from disposal of a subsidiary		8,251
CASH FLOWS (USED IN) PROVIDED BY INVESTING ACTIVITIES	(1,009,445)	8,251
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of bank loan	(30,555)	(29,239)
Advance from related party	36,491	368,340
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES:	5,936	339,101
Effect of exchange rate changes	(21,646)	(19,919)
Net change in cash and cash equivalents	(1,361,071)	(37,959)
Cash and cash equivalents - beginning of period	1,805,417	83,667
Cash and cash equivalents - end of period	444,346	45,708
Cash paid for:
Interest	55,750	95,831
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for director’s remuneration	500,000
Stock issued for redemption of convertible note and accrued interest	$ 104,167